Section Arrow
FLGT.NASDAQ
- Fulgent Genetics
Quotes are at least 15-min delayed:2026/03/29 20:57 EDT
Regular Hours
Last
 15.59
-0.78 (-4.76%)
Day High 
16.25 
Prev. Close
16.37 
1-M High
19.12 
Volume 
599.28K 
Bid
15.38
Ask
15.83
Day Low
15.44 
Open
16.25 
1-M Low
13.46 
Market Cap 
506.04M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 15.71 
20-SMA 15.08 
50-SMA 21.19 
52-W High 31.04 
52-W Low 13.46 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.97/-0.03
Enterprise Value
511.77M
Balance Sheet
Book Value Per Share
35.61
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
322.67M
Operating Revenue Per Share
9.27
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DHRDanaher Corp181.52-6.13-3.27%37.31PE
OPKOPKO Health1.12-0.05-4.27%-- 
PSNLPersonalis6.34-0.98-13.39%-- 
BIAFbioAffinity Technologies Inc4-0.74-15.61%-- 
SHCSotera Health Company13.13-0.41-3.03%50.15PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focusedon developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.